President Donald Trump met with members of his administration to discuss an executive order on drug prices. Ideas under discussion include instructing federal agencies to pursue value-based contracts as well as promote trade regulations that strengthen drugmakers' intellectual property rights.
Sign up for BIO SmartBrief
Biotechnology industry news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.